Home Expert Interviews

Expert Interviews

Bispecific T-Cell Engagers for Multiple Myeloma, with Dr. Chakraborty

Multiple Myeloma Today spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, on bispecific T-cell...

Dr. Chakraborty: Challenges of Quadruplet Therapy for Multiple Myeloma

Multiple Myeloma Today spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, on how new...

Recent Clinical Trials for Newly Diagnosed Multiple Myeloma, with Dr. Raj Chakraborty

DocWire News spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, about promising results from...

Immunotherapy Agents in Development for Multiple Myeloma

Nina Shah, MD, an associate professor in the Department of Medicine at the University of California, San Francisco, discusses immunotherapy agents in the pipeline...

Hematologist Discusses the Multiple Myeloma Pipeline

Sarah Holstein, MD, PhD, associate professor of medicine in the Division of Oncology & Hematology at the University of Nebraska Medical Center, discusses the...

Saad Usmani, M.D., MBA, FACP Discusses Treatments in Multiple Myeloma Patients

DocWire News sat down with Saad Usmani, M.D., MBA, FACP to discuss an indirect treatment comparison study which assesses DARZALEX® (daratumumab) Plus Lenalidomide and...

Dr. Holstein: Targets of Interest for the Treatment of Multiple Myeloma

Sarah Holstein, MD, PhD, associate professor of medicine in the Division of Oncology & Hematology at the University of Nebraska Medical Center, talks about...

Disparities in Clinical Trial Populations and the Impact of COVID-19 on Myeloma Care

Sarah Holstein, MD, PhD, discusses the lack of Black patients with multiple myeloma (MM) enrolled in clinical trials, as well as considerations for patient...

Hematologist Discusses the Impact a Myeloma CAR T-Cell Approval Would Have on the Treatment...

Ankit Kansagra, MD, an assistant professor in the Department of Internal Medicine at UT Southwestern Medical Center and assistant director of the Outpatient Stem Cell Transplant Program,...

Myeloma Expert Discusses the First Approved Anti-BCMA Therapy

Shaji Kumar, MD, consultant in the Division of Hematology and professor of medicine at Mayo Clinic Cancer Center in Rochester, Minnesota, discusses B-cell maturation antigen (BCMA)...